SHARP THERAPEUTICS CORP (SHRX.CA) Stock Income Statement
Canada - TSX-V:SHRX - CA8200092077 - Common Stock
3.62 CAD
-0.01 (-0.28%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 5.19M | 2.54M | 131.80K | 19.90K | 13.50K | |||
| Research and Development | N/A | 2.09M | N/A | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 1.40M | 346.60K | 131.80K | 19.90K | 13.50K | |||
| Operating Income | -5.19M | -2.54M | -131.80K | -19.90K | -13.50K | |||
| Interest Income/Expense | N/A | 1.59M | N/A | N/A | N/A | |||
| Other Income/Expense | N/A | -295.10K | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | -2.01M | N/A | N/A | N/A | |||
| Income Before Taxes | -5.85M | -3.26M | -131.80K | -19.90K | -13.50K | |||
| Net Income | -5.85M | -3.26M | -131.80K | -19.90K | -13.50K | |||
| EBITDA | N/A | -2.44M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.01 | -3.62 | -0.02 | -0.01 | -0.00 | |||
| Statistics | ||||||||
All data in USD